|Articles|August 1, 2003

Examining the Dyslipidemia Constellation
Volume 9
Issue 1 Dyslipid

Inflammatory markers are useful risk assessment tools

Author(s)Peter Libby, MD

Download PDF: Inflammatory markers are useful risk assessment tools

Articles in this issue

over 22 years ago

Article

NCEP ATP III guidelines incorporate global risk assessment

over 22 years ago

Article

Case reports illustrate consequences of ATP III in practice

over 22 years ago

Article

Interview: Intergrating clinical trial results into managed care practice

over 22 years ago

Article

Atherosclerosis target of lipid-lowering therapy: Is Lower LDL cholesterol better?

over 22 years ago

Article

IVUS is redefining atherosclerotic disease

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Inflammatory markers are useful risk assessment tools

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AI-Supported Mammography Caught More Cancers During Screening

The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

Photobiomodulation, Bio-Machines, and the Future of Dermatology